Summary
- Current Price
- As of today, THNR price is $24.90, down -0.29% on
- Current Price vs All-Time High
- THNR price is currently -11.68% below its historical high of $28.19 set on
- Dividend Yield
- THNR current TTM dividend yield is 1.66%
- Next Ex-Dividend
- As of today, the next dividend for THNR has not been scheduled
Profile
| Metric | Value |
|---|---|
| Name | Amplify Weight Loss Drug & Treatment ETF |
| Assets Under Management | $4M |
| Expense Ratio | 0.59% |
| Asset Class | Equity |
| Domicile | US |
| Inception Date | |
| Net Asset Value | 26K USD |
| Website | amplifyetfs.com |
| Last Ex-Dividend Date | |
| Next Ex-Dividend Date | N/A |
Top 30 Holdings
| Name | Ticker | Weight |
|---|---|---|
| LLY | 12.23% | |
| NVO | 9.65% | |
| AMGN | 7.80% | |
| 4519.T | 7.53% | |
| REGN | 6.80% | |
| 4507.T | 6.30% | |
| MRK | 5.87% | |
| ROG.SW | 5.49% | |
| AZN | 5.40% | |
| PFE | 5.28% | |
| ABBV | 5.15% | |
| 1801.HK | 4.82% | |
| 1093.HK | 4.33% | |
| ARWR | 3.66% | |
| VKTX | 1.76% | |
| SRRK | 1.74% | |
| HIMS | 1.56% | |
| AGPXX | 1.45% | |
| ZEAL.CO | 1.12% | |
| 128940.KS | 1.02% | |
| 1276.HK | 0.88% | |
| 0.17% |
Chart
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $24.90 | ||
| $24.28 | ||
| SMA 200 vs Price | -2.51% | |
| $25.36 | ||
| SMA 50 vs Price | +1.83% | |
| 0.69 | ||
| $0.35 | ||
| 54.31 | ||
| 22.57% | ||
| 21.27% |
Dividends
| Metric | Date | Value |
|---|---|---|
| $0.41 | ||
| N/A | N/A | |
| 1.66% | ||
| $0.41 |
Country Weights
| Country | Weight |
|---|---|
| United States | 51.67% |
| Japan | 13.95% |
| Denmark | 10.83% |
| China | 9.71% |
| Switzerland | 5.63% |
| United Kingdom | 5.47% |
| South Korea | 1.16% |
Sector Weights
| Sector | Weight |
|---|---|
| Healthcare | 65.34% |
| Consumer Defensive | 1.56% |
FAQ
Does THNR pay dividends?
Yes, the Amplify Weight Loss Drug & Treatment ETF does pays dividends, with the most recent payment being $0.41 per share. The last ex-dividend date was on December 29, 2025, and the next ex-dividend date has not been announced yet
What stocks are in THNR?
As of today, Amplify Weight Loss Drug & Treatment ETF includes 22 holdings, with 12 of them being companies from 7 different countries and 2 sectors. The most weighted holdings are Eli Lilly and Company (12.23%), Novo Nordisk A/S (9.65%) and Amgen Inc. (7.8%)
What is the current assets under management for THNR?
Assets under management of Amplify Weight Loss Drug & Treatment ETF is $4M
What is THNR average volume?
Average volume of Amplify Weight Loss Drug & Treatment ETF is $7,357
What is THNR expense ratio?
Expense ratio of Amplify Weight Loss Drug & Treatment ETF is 0.59%
What is THNR inception date?
Inception date of Amplify Weight Loss Drug & Treatment ETF is May 21, 2024
Data Sources & References
- THNR Official Website amplifyetfs.com/thnr
- THNR Profile on Yahoo Finance finance.yahoo.com/quote/THNR